StockWatch
·
Pharmaceuticals
Quarterly Result27 Oct 2026, 01:38 pm

Cipla Q2 FY27 Revenue ₹7,404 Cr, PAT ₹878 Cr

AI Summary

Cipla Limited announced its unaudited consolidated financial results for the quarter ended September 30th, 2026. Total income from operations stood at ₹7,404 Cr, a slight decrease of 2% YoY from ₹7,589 Cr in Q2 FY26. EBITDA was ₹1,388 Cr (18.7% of revenue), down from ₹1,895 Cr (25.0% of revenue) in the prior year. Profit After Tax (PAT) was ₹878 Cr, a decrease from ₹1,351 Cr in Q2 FY26. The company highlighted strong performance in its One-India business, which grew 12% YoY. North America delivered quarterly revenue of $172 Mn. R&D investments were ₹423 Cr (5.7% of sales). The company maintained a strong net cash position of ₹9,823 Cr.

Key Highlights

  • Q2 FY27 revenue at ₹7,404 Cr, PAT at ₹878 Cr.
  • One-India business recorded 12% YoY growth.
  • North America revenue was $172 Mn.
  • R&D investments stood at ₹423 Cr (5.7% of sales).
  • Net cash position remains strong at ₹9,823 Cr.